As of October 29, 2026, Jazz Pharmaceuticals had a market cap of $13.47 billion, which increased by 1.35% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from
EDGAR filings,
Bloomberg
and Yahoo Finance.
📈 Jazz Pharmaceuticals Market Cap History by Year and Month
Jazz Pharmaceuticals Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2026
$13.47B
▲ 30.40%
$13.47B
▼ 10.20%
$15B
▼ 7.64%
$16.24B
▲ 2.46%
$15.85B
▲ 4.90%
$15.11B
▲ 1.82%
$14.84B
▲ 18.72%
$12.5B
▲ 7.39%
$11.64B
▼ 0.51%
$11.7B
▲ 17.06%
$9.995B
▼ 3.24%
2025
$10.33B
▲ 38.34%
$10.33B
▼ 3.73%
$10.73B
▲ 28.52%
$8.349B
▲ 4.43%
$7.995B
▲ 3.17%
$7.749B
▲ 11.72%
$6.936B
▲ 8.02%
$6.421B
▼ 1.80%
$6.539B
▼ 9.29%
$7.209B
▼ 5.76%
$7.65B
▼ 12.24%
$8.717B
▲ 15.59%
$7.541B
▲ 0.99%
2024
$7.467B
▼ 3.58%
$7.467B
▲ 1.59%
$7.35B
▲ 10.51%
$6.651B
▼ 1.23%
$6.734B
▼ 5.98%
$7.162B
▲ 5.20%
$6.808B
▲ 1.16%
$6.73B
▲ 1.40%
$6.637B
▼ 4.94%
$6.982B
▼ 7.01%
$7.508B
▲ 1.28%
$7.413B
▼ 2.98%
$7.641B
▼ 1.33%
2023
$7.744B
▼ 22.81%
$7.744B
▲ 4.03%
$7.444B
▼ 6.89%
$7.995B
▼ 2.17%
$8.172B
▼ 9.70%
$9.05B
▲ 9.44%
$8.269B
▲ 5.20%
$7.86B
▼ 4.17%
$8.202B
▼ 8.77%
$8.99B
▼ 3.99%
$9.364B
▲ 5.31%
$8.892B
▼ 10.20%
$9.902B
▼ 1.30%
2022
$10.032B
▲ 27.76%
$10.032B
▲ 1.53%
$9.881B
▲ 9.27%
$9.043B
▲ 7.87%
$8.383B
▼ 13.83%
$9.729B
▼ 0.54%
$9.782B
▲ 0.13%
$9.769B
▲ 4.73%
$9.328B
▼ 6.58%
$9.985B
▲ 3.06%
$9.689B
▲ 14.20%
$8.484B
▼ 0.90%
$8.561B
▲ 9.03%
2021
$7.852B
▼ 15.31%
$7.852B
▲ 6.57%
$7.368B
▼ 9.77%
$8.166B
▲ 2.18%
$7.992B
▼ 1.11%
$8.082B
▼ 22.03%
$10.366B
▼ 4.52%
$10.857B
▲ 0.43%
$10.811B
▲ 15.58%
$9.354B
▲ 0.06%
$9.348B
▼ 1.25%
$9.466B
▲ 8.38%
$8.734B
▼ 5.79%
2020
$9.271B
▲ 10.62%
$9.271B
▲ 18.27%
$7.839B
▼ 2.35%
$8.028B
▲ 1.27%
$7.927B
▲ 6.36%
$7.453B
▲ 24.13%
$6.004B
▼ 1.88%
$6.119B
▼ 7.32%
$6.602B
▲ 8.23%
$6.1B
▲ 10.45%
$5.523B
▼ 14.12%
$6.431B
▼ 20.09%
$8.048B
▼ 3.97%
2019
$8.381B
▲ 17.58%
$8.381B
▼ 1.97%
$8.549B
▲ 20.29%
$7.107B
▼ 2.04%
$7.255B
▼ 0.01%
$7.256B
▼ 8.06%
$7.892B
▼ 2.27%
$8.075B
▲ 13.67%
$7.104B
▼ 3.39%
$7.353B
▼ 9.86%
$8.157B
▲ 2.09%
$7.99B
▲ 10.37%
$7.239B
▲ 1.56%
2018
$7.128B
▼ 11.69%
$7.128B
▼ 21.84%
$9.12B
▼ 4.80%
$9.58B
▼ 5.68%
$10.157B
▼ 1.63%
$10.325B
▼ 1.25%
$10.456B
▲ 0.65%
$10.388B
▲ 2.42%
$10.143B
▲ 11.19%
$9.122B
▲ 1.03%
$9.029B
▲ 4.27%
$8.659B
▼ 0.81%
$8.73B
▲ 8.15%
2017
$8.072B
▲ 23.61%
$8.072B
▼ 3.64%
$8.377B
▼ 1.27%
$8.485B
▼ 3.40%
$8.784B
▼ 2.08%
$8.971B
▼ 2.76%
$9.226B
▼ 1.26%
$9.344B
▲ 6.89%
$8.742B
▼ 8.56%
$9.56B
▲ 9.81%
$8.706B
▲ 9.88%
$7.923B
▲ 8.64%
$7.293B
▲ 11.68%
2016
$6.53B
▼ 24.21%
$6.53B
▲ 5.22%
$6.206B
▼ 5.34%
$6.556B
▼ 10.84%
$7.353B
▼ 1.89%
$7.495B
▼ 17.93%
$9.132B
▲ 6.83%
$8.548B
▼ 6.65%
$9.157B
▲ 0.54%
$9.108B
▲ 15.33%
$7.897B
▲ 6.17%
$7.438B
▼ 5.75%
$7.892B
▼ 8.40%
2015
$8.616B
▼ 13.22%
$8.616B
▼ 4.43%
$9.015B
▲ 6.77%
$8.443B
▲ 3.63%
$8.147B
▼ 21.32%
$10.355B
▼ 12.19%
$11.792B
▲ 9.40%
$10.779B
▼ 1.67%
$10.962B
▲ 0.51%
$10.906B
▲ 3.42%
$10.545B
▲ 2.20%
$10.318B
▲ 0.48%
$10.269B
▲ 3.42%
2014
$9.929B
▲ 35.62%
$9.929B
▼ 7.31%
$10.712B
▲ 4.89%
$10.213B
▲ 5.63%
$9.669B
▼ 1.45%
$9.811B
▲ 16.59%
$8.415B
▼ 3.72%
$8.74B
▲ 3.63%
$8.434B
▲ 5.07%
$8.027B
▼ 2.71%
$8.251B
▼ 6.48%
$8.823B
▲ 0.56%
$8.774B
▲ 19.85%
2013
$7.321B
▲ 137.00%
$7.321B
▲ 8.35%
$6.757B
▲ 28.85%
$5.244B
▼ 1.94%
$5.348B
▲ 4.88%
$5.099B
▲ 16.04%
$4.394B
▲ 9.03%
$4.03B
▲ 0.70%
$4.002B
▲ 16.54%
$3.434B
▲ 5.82%
$3.245B
▼ 3.91%
$3.377B
▲ 3.24%
$3.271B
▲ 5.89%
2012
$3.089B
▲ 89.63%
$3.089B
▼ 0.96%
$3.119B
▲ 1.10%
$3.085B
▼ 5.95%
$3.28B
▲ 25.24%
$2.619B
▼ 5.31%
$2.766B
▲ 7.84%
$2.565B
▲ 4.35%
$2.458B
▼ 15.09%
$2.895B
▲ 6.20%
$2.726B
▼ 7.62%
$2.951B
▲ 49.42%
$1.975B
▲ 21.24%
2011
$1.629B
▲ 107.25%
$1.629B
▼ 2.46%
$1.67B
▲ 1.64%
$1.643B
▼ 5.14%
$1.732B
▼ 3.24%
$1.79B
▲ 5.98%
$1.689B
▲ 24.28%
$1.359B
▲ 13.91%
$1.193B
▼ 8.23%
$1.3B
▲ 0.39%
$1.295B
▲ 30.54%
$0.992B
▲ 10.96%
$0.894B
▲ 13.74%
2010
$0.786B
▲ 219.51%
$0.786B
▲ 21.30%
$0.648B
▲ 56.90%
$0.413B
▼ 0.96%
$0.417B
▲ 20.17%
$0.347B
▲ 26.64%
$0.274B
▲ 10.93%
$0.247B
▼ 3.52%
$0.256B
▼ 20.00%
$0.32B
▼ 6.98%
$0.344B
▲ 12.42%
$0.306B
▲ 4.08%
$0.294B
▲ 19.51%
2009
$0.246B
▲ 340.58%
$0.246B
▲ 4.24%
$0.236B
▲ 21.03%
$0.195B
▼ 21.37%
$0.248B
▲ 9.73%
$0.226B
▲ 24.18%
$0.182B
▲ 70.09%
$0.107B
▲ 269.86%
$28.93M
▲ 81.81%
$15.912M
▼ 38.20%
$25.748M
▲ 20.27%
$21.408M
▼ 22.92%
$27.773M
▼ 50.26%
2008
$55.835M
▼ 84.58%
$55.835M
▲ 29.34%
$43.17M
▼ 49.66%
$85.764M
▼ 39.60%
$0.142B
▼ 30.39%
$0.204B
▲ 5.15%
$0.194B
▼ 8.92%
$0.213B
▲ 13.30%
$0.188B
▼ 15.32%
$0.222B
— 0.00%
$0.222B
▼ 24.49%
$0.294B
▼ 8.98%
$0.323B
▼ 10.77%
2007
$0.362B
▼ 16.78%
$0.362B
▼ 4.99%
$0.381B
▲ 16.16%
$0.328B
▲ 19.27%
$0.275B
▼ 16.67%
$0.33B
▼ 5.17%
$0.348B
▼ 11.45%
$0.393B
▼ 9.66%
All market cap values reflect closing prices for the period shown.
📊 Jazz Pharmaceuticals Market Cap and Other Industry Peers
Below are selected companies from the Health Care sector / subsector: